Karuna Therapeutics Inc (KRTX)
NASDAQ
New Drug Application (NDA) for KarXT for the treatment of schizophrenia in adults under review with a Prescription Drug User Fee Act (PDUFA) action date of September 26, 2024 Results from the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 329.83 | 329.83 | 329.83 | 0 | 0 | CS |
4 | 0 | 0 | 329.83 | 329.83 | 329.83 | 0 | 0 | CS |
12 | 0 | 0 | 329.83 | 329.83 | 329.83 | 0 | 0 | CS |
26 | 0 | 0 | 329.83 | 329.83 | 329.83 | 0 | 0 | CS |
52 | 164.83 | 99.896969697 | 165 | 329.95 | 158.375 | 299657 | 287.40720856 | CS |
156 | 211.13 | 177.868576243 | 118.7 | 329.95 | 92.26 | 310613 | 217.9051369 | CS |
260 | 312.93 | 1851.65680473 | 16.9 | 329.95 | 11.24 | 295528 | 171.04843336 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.